Form 4: Health In Tech Director Sanjay Shrestha Acquires Over 128,000 Shares

Health In Tech, Inc. Director Sanjay K. Shrestha has acquired 128,474 shares of Class A Common Stock at a price of $0.62 per share, totaling approximately $79,654, as part of the company's Equity Incentive Plan.

Summary

• Sanjay K. Shrestha, a Director of Health In Tech, Inc. (HIT), acquired 128,474 shares of Class A Common Stock.
• The transaction occurred on June 23, 2025, with shares priced at $0.62 each.
• The total value of the acquired shares is approximately $79,653.88.
• These shares are restricted and were granted under the Health in Tech Equity Incentive Plan.
• The shares are subject to vesting conditions: either fully upon one year of service commencing April 8, 2025, or partially at the first shareholders' meeting if not fully vested by that date.
• Vesting is contingent upon Mr. Shrestha's continuous service through the vesting date.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, especially as part of an incentive plan, is generally viewed positively as it aligns management's interests with shareholders and indicates confidence in the company's future. There are no negative aspects reported in this specific filing.

Positives

• The acquisition by a director indicates alignment of interests between management and shareholders, potentially signaling confidence in the company's future.
• The grant is part of an equity incentive plan, which is a common practice to motivate and retain key personnel.

Risks

• The vesting of the restricted shares is contingent upon continuous service, meaning the director must remain with the company for the shares to fully vest.
• The value of the shares is subject to market fluctuations, and the actual realized value upon vesting could be higher or lower than the grant price.

Future Outlook

The future ownership of these shares by Director Sanjay K. Shrestha is tied to a vesting schedule, with full vesting expected after one year of continuous service from April 8, 2025, or partial vesting at the first shareholders' meeting if not fully vested by then.

Management Comments

• The grant of 128,474 restricted shares of Class A Common Stock to Director Sanjay K. Shrestha was made pursuant to the Health in Tech Equity Incentive Plan, aligning his interests with long-term shareholder value.

Industry Context

This Form 4 filing reflects an insider transaction, a common occurrence in publicly traded companies where executives and directors receive equity as part of their compensation or incentive plans. Such transactions are closely watched by investors for signals regarding management's confidence in the company's prospects.

Corporate Governance

Related Party Transactions

• The acquisition of 128,474 shares of Class A Common Stock by Sanjay K. Shrestha, a Director of Health In Tech, Inc., constitutes a related party transaction as it involves an insider of the company.

Stakeholder Impact

• Shareholders: The acquisition by a director can be seen as a positive signal, potentially increasing confidence in the company's future performance and aligning management's interests with shareholder returns.
• Employees: The existence of an Equity Incentive Plan suggests a framework for employee and executive compensation that could extend to other key personnel, fostering a sense of ownership and commitment.

Next Steps

• The restricted shares will vest either fully upon one year of service commencing April 8, 2025, or partially at the first shareholders' meeting if not fully vested by that date, subject to continuous service.

Key Dates

Keywords

Health In Tech, HIT, Sanjay Shrestha, SEC Form 4, Insider Trading, Stock Acquisition, Restricted Stock, Equity Incentive Plan, Director, Common Stock, Beneficial Ownership